Trial Profile
Phase I Study to Determine the Safety and Feasibility of the Use of a Combination Stem Cell Therapy in Patients With Acute Myocardial Infarction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2014
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- Sponsors TCA Cellular Therapy
- 21 Apr 2014 New trial record